Difficulty: Medium
Average Score: 87%
Practice
A 70-year-old female with osteoporosis is prescribed denosumab. Denosumab works by:
Correct answer
B
Rationale
The correct answer is B: Inhibiting osteoclast-mediated bone resorption. Denosumab is a monoclonal antibody that works by inhibiting osteoclast activity, thereby reducing bone resorption. Osteoclasts are responsible for breaking down bone tissue, so inhibiting their function helps to prevent bone loss in conditions like osteoporosis. Choices A and C are incorrect as denosumab does not directly increase bone formation or promote osteoblast activity. Choice D is also incorrect as denosumab does not affect calcium absorption in the intestines.